TyG指数与胰岛素抵抗及其相关代谢性疾病的研究进展
Research Progress on the TyG Index for Insulin Resistance and Associated Metabolic Diseases
DOI: 10.12677/acm.2025.1561868, PDF,   
作者: 田 柳*, 潘建鑫#：重庆医科大学附属大学城医院健康管理中心，重庆
关键词: 甘油三酯–葡萄糖指数；胰岛素抵抗；代谢性疾病；Triglyceride-Glucose Index； Insulin Resistance； Metabolic Diseases
摘要: 目前我国高血压、高血糖、肥胖、脂代谢异常等代谢性疾病发病率随社会发展持续上升，显著增加心血管疾病、2型糖尿病、代谢相关脂肪性疾病、代谢综合征等慢性非传染性疾病发病风险。胰岛素抵抗(insulin resistance, IR)作为核心病理机制，其早期识别对疾病防控至关重要。甘油三酯–葡萄糖指数(triglyceride-glucose index, TyG index)通过空腹甘油三酯与血糖乘积的对数值计算，作为新型非侵入性生物标志物，在评估胰岛素抵抗及预测代谢性疾病风险中展现独特优势。本综述将对TyG指数与胰岛素抵抗的作用机制作基本概括，重点阐述其在代谢性疾病诊断、风险预测及临床管理中的应用价值，以期为疾病的预防和治疗及临床综合管理提供一种思路和研究方向。
Abstract: In the context of China’s ongoing societal progression, the incidence of metabolic disorders, including hypertension, hyperglycemia, obesity, and dyslipidemia, is witnessing a relentless surge, significantly exacerbating the risk of chronic non-communicable diseases including cardiovascular diseases, type 2 diabetes mellites, metabolic-associated fatty liver disease, and metabolic syndrome. Insulin resistance (IR), as a core pathological mechanism, is crucial for early identification in disease prevention and control. Triglyceride-glucose (TyG) index, calculated as the logarithmic product of fasting triglycerides and glucose, serves as a novel non-invasive biomarker and demonstrates unique advantages in assessing IR and predicting the risk of metabolic diseases. This review will provide a basic overview of the mechanisms underlying TyG index and IR, with a focus on its application value in the diagnosis, risk prediction, and clinical management of metabolic diseases, aiming to offer insights and research directions for disease prevention, treatment, and comprehensive clinical management.
文章引用：田柳, 潘建鑫. TyG指数与胰岛素抵抗及其相关代谢性疾病的研究进展[J]. 临床医学进展, 2025, 15(6): 1420-1429. https://doi.org/10.12677/acm.2025.1561868

参考文献

[1] Zhou, M., Wang, H., Zeng, X., Yin, P., Zhu, J., Chen, W., et al. (2019) Mortality, Morbidity, and Risk Factors in China and Its Provinces, 1990-2017: A Systematic Analysis for the Global Burden of Disease Study 2017. The Lancet, 394, 1145-1158. [Google Scholar] [CrossRef] [PubMed]
[2] 宋林阳, 胡依萌, 徐焱成, 等. 胰岛素抵抗的再认识[J]. 中华糖尿病杂志, 2022, 14(12): 1341-1347.
[3] Leite, M.M., Dutra, M.T., da Costa, M.V.G., Funghetto, S.S., Silva, A.d.O., de Lima, L.R., et al. (2021) Comparative Evaluation of Inflammatory Parameters and Substitute Insulin Resistance Indices in Elderly Women with and without Type 2 Diabetes Mellitus. Experimental Gerontology, 150, Article 111389. [Google Scholar] [CrossRef] [PubMed]
[4] Gluvic, Z., Zaric, B., Resanovic, I., Obradovic, M., Mitrovic, A., Radak, D., et al. (2016) Link between Metabolic Syndrome and Insulin Resistance. Current Vascular Pharmacology, 15, 30-39. [Google Scholar] [CrossRef] [PubMed]
[5] Pulakat, L., DeMarco, V.G., Ardhanari, S., Chockalingam, A., Gul, R., Whaley-Connell, A., et al. (2011) Adaptive Mechanisms to Compensate for Overnutrition-Induced Cardiovascular Abnormalities. American Journal of Physiology-Regulatory, Integrative and Comparative Physiology, 301, R885-R895. [Google Scholar] [CrossRef] [PubMed]
[6] Yokota, T., Kinugawa, S., Hirabayashi, K., Yamato, M., Takada, S., Suga, T., et al. (2021) Systemic Oxidative Stress Is Associated with Lower Aerobic Capacity and Impaired Skeletal Muscle Energy Metabolism in Heart Failure Patients. Scientific Reports, 11, Article No. 2272. [Google Scholar] [CrossRef] [PubMed]
[7] Marassi, M. and Fadini, G.P. (2023) The Cardio-Renal-Metabolic Connection: A Review of the Evidence. Cardiovascular Diabetology, 22, Article No. 195. [Google Scholar] [CrossRef] [PubMed]
[8] James, D.E., Stöckli, J. and Birnbaum, M.J. (2021) The Aetiology and Molecular Landscape of Insulin Resistance. Nature Reviews Molecular Cell Biology, 22, 751-771. [Google Scholar] [CrossRef] [PubMed]
[9] Lee, S., Park, S. and Choi, C.S. (2022) Insulin Resistance: From Mechanisms to Therapeutic Strategies. Diabetes & Metabolism Journal, 46, 15-37. [Google Scholar] [CrossRef] [PubMed]
[10] 苏青, 臧丽. 胰岛素抵抗的历史、机制和管理[J]. 中华糖尿病杂志, 2023, 15(1): 6-13.
[11] Mocciaro, G. and Gastaldelli, A. (2022) Obesity-Related Insulin Resistance: The Central Role of Adipose Tissue Dysfunction. In: Eckel, J. and Clément, K., Eds., Handbook of Experimental Pharmacology, Springer International Publishing, 145-164. [Google Scholar] [CrossRef] [PubMed]
[12] Chibalin, A.V., Leng, Y., Vieira, E., Krook, A., Björnholm, M., Long, Y.C., et al. (2022) Downregulation of Diacylglycerol Kinase Delta Contributes to Hyperglycemia-Induced Insulin Resistance. Cell, 185, 397-398. [Google Scholar] [CrossRef] [PubMed]
[13] Wallace, T.M., Levy, J.C. and Matthews, D.R. (2004) Use and Abuse of HOMA Modeling. Diabetes Care, 27, 1487-1495. [Google Scholar] [CrossRef] [PubMed]
[14] Bornfeldt, K.E. and Tabas, I. (2011) Insulin Resistance, Hyperglycemia, and Atherosclerosis. Cell Metabolism, 14, 575-585. [Google Scholar] [CrossRef] [PubMed]
[15] Nayak, V.K.R., Satheesh, P., Shenoy, M.T. and Kalra, S. (2022) Triglyceride Glucose (TyG) Index: A Surrogate Biomarker of Insulin Resistance. Journal of the Pakistan Medical Association, 72, 986-988. [Google Scholar] [CrossRef] [PubMed]
[16] Simental-Mendía, L.E., Rodríguez-Morán, M. and Guerrero-Romero, F. (2008) The Product of Fasting Glucose and Triglycerides as Surrogate for Identifying Insulin Resistance in Apparently Healthy Subjects. Metabolic Syndrome and Related Disorders, 6, 299-304. [Google Scholar] [CrossRef] [PubMed]
[17] Lee, S., Han, K., Yang, H.K., Kim, M.K., Yoon, K., Kwon, H., et al. (2014) Identifying Subgroups of Obesity Using the Product of Triglycerides and Glucose: The Korea National Health and Nutrition Examination Survey, 2008-2010. Clinical Endocrinology, 82, 213-220. [Google Scholar] [CrossRef] [PubMed]
[18] Zhang, M., Wang, B., Liu, Y., Sun, X., Luo, X., Wang, C., et al. (2017) Cumulative Increased Risk of Incident Type 2 Diabetes Mellitus with Increasing Triglyceride Glucose Index in Normal-Weight People: The Rural Chinese Cohort Study. Cardiovascular Diabetology, 16, Article No. 30. [Google Scholar] [CrossRef] [PubMed]
[19] Lopez-Jaramillo, P., Gomez-Arbelaez, D., Martinez-Bello, D., Abat, M.E.M., Alhabib, K.F., Avezum, Á., et al. (2023) Association of the Triglyceride Glucose Index as a Measure of Insulin Resistance with Mortality and Cardiovascular Disease in Populations from Five Continents (PURE Study): A Prospective Cohort Study. The Lancet Healthy Longevity, 4, e23-e33. [Google Scholar] [CrossRef] [PubMed]
[20] Son, D., Lee, H.S., Lee, Y., Lee, J. and Han, J. (2022) Comparison of Triglyceride-Glucose Index and HOMA-IR for Predicting Prevalence and Incidence of Metabolic Syndrome. Nutrition, Metabolism and Cardiovascular Diseases, 32, 596-604. [Google Scholar] [CrossRef] [PubMed]
[21] Manolis, A.A., Manolis, T.A., Melita, H. and Manolis, A.S. (2018) Psoriasis and Cardiovascular Disease: The Elusive Link. International Reviews of Immunology, 38, 33-54. [Google Scholar] [CrossRef] [PubMed]
[22] Zheng, S., Shi, S., Ren, X., Han, T., Li, Y., Chen, Y., et al. (2016) Triglyceride Glucose-Waist Circumference, a Novel and Effective Predictor of Diabetes in First-Degree Relatives of Type 2 Diabetes Patients: Cross-Sectional and Prospective Cohort Study. Journal of Translational Medicine, 14, Article No. 260. [Google Scholar] [CrossRef] [PubMed]
[23] Galicia-Garcia, U., Benito-Vicente, A., Jebari, S., Larrea-Sebal, A., Siddiqi, H., Uribe, K.B., et al. (2020) Pathophysiology of Type 2 Diabetes Mellitus. International Journal of Molecular Sciences, 21, Article 6275. [Google Scholar] [CrossRef] [PubMed]
[24] Kramer, C.K., Zinman, B. and Retnakaran, R. (2013) Short-Term Intensive Insulin Therapy in Type 2 Diabetes Mellitus: A Systematic Review and Meta-Analysis. The Lancet Diabetes & Endocrinology, 1, 28-34. [Google Scholar] [CrossRef] [PubMed]
[25] Schlesinger, S., Neuenschwander, M., Barbaresko, J., Lang, A., Maalmi, H., Rathmann, W., et al. (2022) Prediabetes and Risk of Mortality, Diabetes-Related Complications and Comorbidities: Umbrella Review of Meta-Analyses of Prospective Studies. Diabetologia, 65, 275-285. [Google Scholar] [CrossRef] [PubMed]
[26] Ong, K.L., Stafford, L.K., McLaughlin, S.A., Boyko, E.J., Vollset, S.E., Smith, A.E., et al. (2023) Global, Regional, and National Burden of Diabetes from 1990 to 2021, with Projections of Prevalence to 2050: A Systematic Analysis for the Global Burden of Disease Study 2021. The Lancet, 402, 203-234. [Google Scholar] [CrossRef] [PubMed]
[27] Xu, Y., Lu, J., Li, M., Wang, T., Wang, K., Cao, Q., et al. (2024) Diabetes in China Part 1: Epidemiology and Risk Factors. The Lancet Public Health, 9, e1089-e1097. [Google Scholar] [CrossRef] [PubMed]
[28] Er, L., Wu, S., Chou, H., Hsu, L., Teng, M., Sun, Y., et al. (2016) Triglyceride Glucose-Body Mass Index Is a Simple and Clinically Useful Surrogate Marker for Insulin Resistance in Nondiabetic Individuals. PLOS ONE, 11, e0149731. [Google Scholar] [CrossRef] [PubMed]
[29] Chen, X., Liu, Z., Yang, Y., Chen, G., Wan, Q., Qin, G., et al. (2022) Depression Status, Lifestyle, and Metabolic Factors with Subsequent Risk for Major Cardiovascular Events: The China Cardiometabolic Disease and Cancer Cohort (4C) Study. Frontiers in Cardiovascular Medicine, 9, Article 865063. [Google Scholar] [CrossRef] [PubMed]
[30] da Silva, A., Caldas, A.P.S., Rocha, D.M.U.P. and Bressan, J. (2020) Triglyceride-Glucose Index Predicts Independently Type 2 Diabetes Mellitus Risk: A Systematic Review and Meta-Analysis of Cohort Studies. Primary Care Diabetes, 14, 584-593. [Google Scholar] [CrossRef] [PubMed]
[31] Zhang, Q., Xiao, S., Jiao, X. and Shen, Y. (2023) The Triglyceride-Glucose Index Is a Predictor for Cardiovascular and All-Cause Mortality in CVD Patients with Diabetes or Pre-Diabetes: Evidence from NHANES 2001-2018. Cardiovascular Diabetology, 22, Article No. 279. [Google Scholar] [CrossRef] [PubMed]
[32] Tai, S., Fu, L., Zhang, N., Yang, R., Zhou, Y., Xing, Z., et al. (2022) Association of the Cumulative Triglyceride-Glucose Index with Major Adverse Cardiovascular Events in Patients with Type 2 Diabetes. Cardiovascular Diabetology, 21, Article No. 161. [Google Scholar] [CrossRef] [PubMed]
[33] Yan, H., Zhou, Q., Wang, Y., Tu, Y., Zhao, Y., Yu, J., et al. (2024) Associations between Cardiometabolic Indices and the Risk of Diabetic Kidney Disease in Patients with Type 2 Diabetes. Cardiovascular Diabetology, 23, Article No. 142. [Google Scholar] [CrossRef] [PubMed]
[34] Wang, D., Yang, Y., Lei, Y., Tzvetkov, N.T., Liu, X., Yeung, A.W.K., et al. (2019) Targeting Foam Cell Formation in Atherosclerosis: Therapeutic Potential of Natural Products. Pharmacological Reviews, 71, 596-670. [Google Scholar] [CrossRef] [PubMed]
[35] 中华医学会健康管理学分会,《中华健康管理学杂志》编辑委员会, 国家老年疾病临床医学研究中心. 成人代谢综合征防控健康教育专家共识[J]. 中华健康管理学杂志, 2024, 18(2): 81-92.
[36] Xi, B., He, D., Hu, Y. and Zhou, D. (2013) Prevalence of Metabolic Syndrome and Its Influencing Factors among the Chinese Adults: The China Health and Nutrition Survey in 2009. Preventive Medicine, 57, 867-871. [Google Scholar] [CrossRef] [PubMed]
[37] Luo, W., Ai, L., Wang, B. and Zhou, Y. (2019) High Glucose Inhibits Myogenesis and Induces Insulin Resistance by Down-Regulating AKT Signaling. Biomedicine & Pharmacotherapy, 120, Article 109498. [Google Scholar] [CrossRef] [PubMed]
[38] Kang, S.W., Kim, S.K., Kim, Y.S. and Park, M. (2023) Risk Prediction of the Metabolic Syndrome Using Tyg Index and SNPs: A 10-Year Longitudinal Prospective Cohort Study. Molecular and Cellular Biochemistry, 478, 39-45. [Google Scholar] [CrossRef] [PubMed]
[39] Wei, X., Min, Y., Song, G., Ye, X. and Liu, L. (2024) Association between Triglyceride-Glucose Related Indices with the All-Cause and Cause-Specific Mortality among the Population with Metabolic Syndrome. Cardiovascular Diabetology, 23, Article No. 134. [Google Scholar] [CrossRef] [PubMed]
[40] Yu, X., Wang, L., Zhang, W., Ming, J., Jia, A., Xu, S., et al. (2018) Fasting Triglycerides and Glucose Index Is More Suitable for the Identification of Metabolically Unhealthy Individuals in the Chinese Adult Population: A Nationwide Study. Journal of Diabetes Investigation, 10, 1050-1058. [Google Scholar] [CrossRef] [PubMed]
[41] Eda Kaya, Yusuf Yilmaz. 累及全身多系统的疾病: 代谢相关(非酒精性)脂肪性肝病[J]. 中华肝脏病杂志, 2025, 33(1): 77-87.
[42] Paik, J.M., Henry, L., Younossi, Y., Ong, J., Alqahtani, S. and Younossi, Z.M. (2023) The Burden of Nonalcoholic Fatty Liver Disease (NAFLD) Is Rapidly Growing in Every Region of the World from 1990 to 2019. Hepatology Communications, 7, e0251. [Google Scholar] [CrossRef] [PubMed]
[43] Younossi, Z.M., Golabi, P., Paik, J.M., Henry, A., Van Dongen, C. and Henry, L. (2023) The Global Epidemiology of Nonalcoholic Fatty Liver Disease (NAFLD) and Nonalcoholic Steatohepatitis (NASH): A Systematic Review. Hepatology, 77, 1335-1347. [Google Scholar] [CrossRef] [PubMed]
[44] Zhou, X., Cai, J., Targher, G., Byrne, C.D., Shapiro, M.D., Sung, K., et al. (2022) Metabolic Dysfunction-Associated Fatty Liver Disease and Implications for Cardiovascular Risk and Disease Prevention. Cardiovascular Diabetology, 21, Article No. 270. [Google Scholar] [CrossRef] [PubMed]
[45] Guo, W., Lu, J., Qin, P., Li, X., Zhu, W., Wu, J., et al. (2020) The Triglyceride-Glucose Index Is Associated with the Severity of Hepatic Steatosis and the Presence of Liver Fibrosis in Non-Alcoholic Fatty Liver Disease: A Cross-Sectional Study in Chinese Adults. Lipids in Health and Disease, 19, Article No. 218. [Google Scholar] [CrossRef] [PubMed]
[46] Kitae, A., Hashimoto, Y., Hamaguchi, M., Obora, A., Kojima, T. and Fukui, M. (2019) The Triglyceride and Glucose Index Is a Predictor of Incident Nonalcoholic Fatty Liver Disease: A Population-Based Cohort Study. Canadian Journal of Gastroenterology and Hepatology, 2019, Article 5121574. [Google Scholar] [CrossRef] [PubMed]
[47] Liu, Y.T., Wang, W., Tong, J. and Wang, B.Y. (2021) Relationship between Triglyceride-Glucose Index and Non-Alcoholic Fatty Liver Disease. Chinese Journal of Hepatology, 29, 451-455. [Google Scholar] [CrossRef] [PubMed]
[48] Sánchez-García, A., Rodríguez-Gutiérrez, R., Mancillas-Adame, L., González-Nava, V., Díaz González-Colmenero, A., Solis, R.C., et al. (2020) Diagnostic Accuracy of the Triglyceride and Glucose Index for Insulin Resistance: A Systematic Review. International Journal of Endocrinology, 2020, Article 4678526. [Google Scholar] [CrossRef] [PubMed]
[49] Zheng, R., Du, Z., Wang, M., Mao, Y. and Mao, W. (2018) A Longitudinal Epidemiological Study on the Triglyceride and Glucose Index and the Incident Nonalcoholic Fatty Liver Disease. Lipids in Health and Disease, 17, Article No. 262. [Google Scholar] [CrossRef] [PubMed]
[50] Mensah, G.A., Fuster, V. and Roth, G.A. (2023) A Heart-Healthy and Stroke-Free World. Journal of the American College of Cardiology, 82, 2343-2349. [Google Scholar] [CrossRef] [PubMed]
[51] Chong, B., Jayabaskaran, J., Jauhari, S.M., Chan, S.P., Goh, R., Kueh, M.T.W., et al. (2024) Global Burden of Cardiovascular Diseases: Projections from 2025 to 2050. European Journal of Preventive Cardiology, 13, zwae281. [Google Scholar] [CrossRef] [PubMed]
[52] 徐倩, 姜志胜. 动脉粥样硬化机制研究的新认识[J]. 中国动脉硬化杂志, 2024, 32(11): 921-931.
[53] Sánchez‐Íñigo, L., Navarro‐González, D., Fernández‐Montero, A., Pastrana‐Delgado, J. and Martínez, J.A. (2016) The Tyg Index May Predict the Development of Cardiovascular Events. European Journal of Clinical Investigation, 46, 189-197. [Google Scholar] [CrossRef] [PubMed]
[54] Park, K., Ahn, C.W., Lee, S.B., Kang, S., Nam, J.S., Lee, B.K., et al. (2019) Elevated Tyg Index Predicts Progression of Coronary Artery Calcification. Diabetes Care, 42, 1569-1573. [Google Scholar] [CrossRef] [PubMed]
[55] Liang, S., Wang, C., Zhang, J., Liu, Z., Bai, Y., Chen, Z., et al. (2023) Triglyceride-Glucose Index and Coronary Artery Disease: A Systematic Review and Meta-Analysis of Risk, Severity, and Prognosis. Cardiovascular Diabetology, 22, Article No. 170. [Google Scholar] [CrossRef] [PubMed]
[56] Sun, C., Hu, L., Li, X., Zhang, X., Chen, J., Li, D., et al. (2024) Triglyceride‐Glucose Index’s Link to Cardiovascular Outcomes Post‐Percutaneous Coronary Intervention in China: A Meta‐Analysis. ESC Heart Failure, 11, 1317-1328. [Google Scholar] [CrossRef] [PubMed]
[57] Zuo, H., Yang, X., Liu, Q., Zhang, Y., Zeng, H., Yan, J., et al. (2018) Global Longitudinal Strain at Rest for Detection of Coronary Artery Disease in Patients without Diabetes Mellitus. Current Medical Science, 38, 413-421. [Google Scholar] [CrossRef] [PubMed]
[58] He, G., Zhang, Z., Wang, C., Wang, W., Bai, X., He, L., et al. (2024) Association of the Triglyceride-Glucose Index with All-Cause and Cause-Specific Mortality: A Population-Based Cohort Study of 3.5 Million Adults in China. The Lancet Regional Health-Western Pacific, 49, Article 101135. [Google Scholar] [CrossRef] [PubMed]

为你推荐